The goal of this non-interventional, retrospective data analysis is to validate the circle method for patients with bicuspid aortic heart valves undergoing transcatheter aortic heart valve implantation (TAVI).
The main aims are:
* to assess whether patients with bicuspid aortic valves that received a TAVI suffered from fewer complications
* if valve size was identical to the one determined using the circle method compared to * a case where circle method derived valve size is different from the actually implanted valve * to develop recommendations on how to size the valve using the circle method.
Patients with bicuspid aortic valves who underwent aortic valve replacement with a balloon expandable valve (SAPIEN 3 / Ultra)
Computed Tomography data available
None
Adult patients with bicuspid valve disease who underwent aortic valve replacement.
Case-only
Other
Not listed
Complications
To assess whether patients with bicuspid aortic valves that received a SAPIEN 3 / Ultra THV suffered from fewer complications * if valve size was identical to the one determined using the circle method compared to * a case where circle method derived valve size is different from the actually implanted valve
Sizing with Circle Method
To develop recommendations on how to size the valve using the circle method.
Click on the lead sponsor to view all of their trials.
Institut für Pharmakologie und Präventive Medizin
Lead sponsor
Edwards Lifesciences
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
